Michael H. Davidson, MD
individual
About
Michael H. Davidson is a cardiologist, lipidology expert, biotech founder-operator, and longtime academic physician. He is CEO of NewAmsterdam Pharma and Executive Chairman/co-founder of SonoThera, and has previously founded or led Omthera Pharmaceuticals and Corvidia Therapeutics through major exits. He also serves across biotech boards in cardiometabolic, aging, drug-delivery, and related therapeutic areas.
Areas of interest
lipidologypreventive cardiologycardiometabolic diseasebiotechdrug deliverygene therapynanomedicineaging biologyobesity therapeuticsclinical researchcannabis therapeutics